Revenue growth remains highly inconsistent, fluctuating from a 9.0% contraction in 2025Q4 to a 6.7% increase in 2026Q1, while operating margins have frequently turned negative, including a -42.3% margin in 2024Q4.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 522.88M | 515.11M | 547.31M | 579.37M | 609.62M | 557.68M | 458.7M | 468.19M | 454.27M | 355.05M | 312.11M | 289.38M | 298.63M | 381.02M | 366.19M | 304.43M | 229.62M | 209.33M | 237.54M | 216.66M | 193.77M | 189.8M | 150.85M | 124.86M | 100.67M | 87.02M | 77.98M | 69.21M | 67M | 67.7M | 48.6M |
| Revenue Growth % | -0.96% | -5.88% | -5.53% | -4.96% | 9.31% | 21.58% | -2.03% | 3.06% | 27.95% | 13.76% | 7.85% | -3.1% | -21.62% | 4.05% | 20.29% | 32.58% | 9.69% | -11.88% | 9.64% | 11.81% | 2.09% | 25.81% | 20.82% | 24.03% | 15.69% | 11.59% | 12.67% | 3.3% | -1.03% | 39.3% | -12.27% |
| Cost of Goods Sold | 367.1M | 367.55M | 426.99M | 400.21M | 368.26M | 386.95M | 286.11M | 290.83M | 271.64M | 207.66M | 183.82M | 177.48M | 184.14M | 209.67M | 205.06M | 181.36M | 140.54M | 148.9M | 136.41M | 120.93M | 111.41M | 104.12M | 78.6M | 65.99M | 56.8M | 45.2M | 38.46M | 32.73M | 36.8M | 37.6M | 26M |
| COGS % of Revenue | - | 71.35% | 78.02% | 69.08% | 60.41% | 69.39% | 62.37% | 62.12% | 59.8% | 58.49% | 58.9% | 61.33% | 61.66% | 55.03% | 56% | 59.57% | 61.2% | 71.13% | 57.43% | 55.82% | 57.5% | 54.86% | 52.1% | 52.85% | 56.42% | 51.94% | 49.32% | 47.3% | 54.93% | 55.54% | 53.5% |
| Gross Profit | 155.79M | 147.56M | 120.32M | 179.16M | 241.35M | 170.72M | 172.59M | 177.35M | 182.63M | 147.39M | 128.29M | 111.9M | 114.5M | 171.35M | 161.13M | 123.07M | 89.08M | 60.43M | 101.13M | 95.73M | 82.36M | 85.68M | 72.26M | 58.87M | 43.88M | 41.82M | 39.52M | 36.48M | 30.2M | 30.1M | 22.6M |
| Gross Margin % | 29.79% | 28.65% | 21.98% | 30.92% | 39.59% | 30.61% | 37.63% | 37.88% | 40.2% | 41.51% | 41.1% | 38.67% | 38.34% | 44.97% | 44% | 40.43% | 38.8% | 28.87% | 42.57% | 44.18% | 42.5% | 45.14% | 47.9% | 47.15% | 43.58% | 48.06% | 50.68% | 52.7% | 45.07% | 44.46% | 46.5% |
| Gross Profit Growth % | - | 22.64% | -32.85% | -25.77% | 41.37% | -1.08% | -2.69% | -2.89% | 23.91% | 14.89% | 14.64% | -2.27% | -33.18% | 6.34% | 30.92% | 38.15% | 47.42% | -40.25% | 5.64% | 16.24% | -3.88% | 18.57% | 22.73% | 34.18% | 4.92% | 5.81% | 8.35% | 20.79% | 0.33% | 33.19% | -19.57% |
| Operating Expenses | 147.34M | 133.79M | 221.87M | 155.87M | 200.7M | 139.78M | 149.68M | 151.13M | 143.61M | 120.6M | 107.75M | 100.38M | 107.79M | 115.61M | 101.8M | 83.84M | 69.89M | 66.75M | 64.99M | 59.72M | 53.14M | 53.41M | 47.3M | 42.33M | 32M | 31.45M | 30.69M | 29.5M | 26.1M | 25.3M | 19.1M |
| OpEx % of Revenue | - | 25.97% | 40.54% | 26.9% | 32.92% | 25.06% | 32.63% | 32.28% | 31.61% | 33.97% | 34.52% | 34.69% | 36.09% | 30.34% | 27.8% | 27.54% | 30.44% | 31.89% | 27.36% | 27.56% | 27.43% | 28.14% | 31.35% | 33.9% | 31.78% | 36.15% | 39.36% | 42.62% | 38.96% | 37.37% | 39.3% |
| Selling, General & Admin | 102.29M | 98.51M | 119.63M | 116.89M | 154.93M | 111.09M | 115.28M | 127.06M | 117.18M | 94.52M | 86.45M | 81.57M | 86.58M | 93.97M | 81.05M | 65.8M | 57.26M | 56.13M | 64.99M | 59.72M | 53.14M | 53.41M | 47.3M | 42.33M | 32M | 32.21M | 27.75M | 26.28M | 23M | 22.6M | 16.8M |
| SG&A % of Revenue | - | 19.12% | 21.86% | 20.17% | 25.41% | 19.92% | 25.13% | 27.14% | 25.8% | 26.62% | 27.7% | 28.19% | 28.99% | 24.66% | 22.13% | 21.61% | 24.94% | 26.81% | 27.36% | 27.56% | 27.43% | 28.14% | 31.35% | 33.9% | 31.78% | 37.02% | 35.58% | 37.98% | 34.33% | 33.38% | 34.57% |
| Research & Development | 22.75M | 23.16M | 32.66M | 38.02M | 31.82M | 28.86M | 26.31M | 24.07M | 26.43M | 26.08M | 21.3M | 18.81M | 21.21M | 21.64M | 20.75M | 18.04M | 12.63M | 10.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | 4.5% | 5.97% | 6.56% | 5.22% | 5.17% | 5.74% | 5.14% | 5.82% | 7.34% | 6.82% | 6.5% | 7.1% | 5.68% | 5.67% | 5.93% | 5.5% | 5.08% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 4M | 12.12M | 69.58M | 957K | 13.95M | -171K | 8.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -761.9K | 2.95M | 3.21M | 3.1M | 2.7M | 2.3M |
| Operating Income | 8.44M | 13.77M | -101.56M | 23.3M | 40.65M | 30.95M | 22.91M | 26.22M | 39.02M | 26.79M | 20.54M | 11.52M | 6.71M | 55.73M | 59.32M | 39.23M | 19.19M | -6.33M | 36.14M | 36.01M | 29.22M | 32.27M | 24.96M | 16.54M | 11.88M | 10.37M | 8.83M | 6.98M | 4.1M | 4.8M | 3.5M |
| Operating Margin % | 1.61% | 2.67% | -18.56% | 4.02% | 6.67% | 5.55% | 4.99% | 5.6% | 8.59% | 7.55% | 6.58% | 3.98% | 2.25% | 14.63% | 16.2% | 12.89% | 8.36% | -3.02% | 15.22% | 16.62% | 15.08% | 17% | 16.54% | 13.25% | 11.8% | 11.91% | 11.32% | 10.08% | 6.12% | 7.09% | 7.2% |
| Operating Income Growth % | - | 113.56% | -535.95% | -42.7% | 31.36% | 35.09% | -12.63% | -32.8% | 45.63% | 30.45% | 78.24% | 71.74% | -87.96% | -6.05% | 51.23% | 104.4% | 403.22% | -117.51% | 0.36% | 23.26% | -9.46% | 29.29% | 50.88% | 39.25% | 14.59% | 17.44% | 26.51% | 70.2% | -14.58% | 37.14% | -41.67% |
| EBITDA | 27.13M | 32.51M | -79.01M | 45.08M | 62.79M | 57.12M | 42.81M | 44.86M | 57.91M | 43.75M | 36.87M | 28M | 23.04M | 70.58M | 72.81M | 52.77M | 33.57M | 7.16M | 47.76M | 46.1M | 35.89M | 39.28M | 30.76M | 20.59M | 14.22M | 12.51M | 11.78M | 10.19M | 7.2M | 7.5M | 5.8M |
| EBITDA Margin % | 5.19% | 6.31% | -14.44% | 7.78% | 10.3% | 10.24% | 9.33% | 9.58% | 12.75% | 12.32% | 11.81% | 9.68% | 7.72% | 18.52% | 19.88% | 17.33% | 14.62% | 3.42% | 20.11% | 21.28% | 18.52% | 20.7% | 20.39% | 16.49% | 14.12% | 14.38% | 15.1% | 14.73% | 10.75% | 11.08% | 11.93% |
| EBITDA Growth % | 130.1% | 141.15% | -275.28% | -28.21% | 9.93% | 33.42% | -4.58% | -22.53% | 32.37% | 18.68% | 31.68% | 21.51% | -67.35% | -3.06% | 37.97% | 57.19% | 369.01% | -85.01% | 3.59% | 28.45% | -8.64% | 27.72% | 49.35% | 44.86% | 13.63% | 6.23% | 15.54% | 41.57% | -4% | 29.31% | -38.3% |
| D&A (Non-Cash Add-back) | 18.68M | 18.74M | 22.55M | 21.78M | 22.14M | 26.17M | 19.9M | 18.64M | 18.89M | 16.96M | 16.33M | 16.47M | 16.33M | 14.85M | 13.49M | 13.55M | 14.38M | 13.49M | 11.61M | 10.09M | 6.67M | 7.02M | 5.8M | 4.05M | 2.34M | 2.14M | 2.95M | 3.21M | 3.1M | 2.7M | 2.3M |
| EBIT | -24.93M | -30.53M | -31.98M | 22.94M | 40.65M | 30.83M | 23.39M | 26.22M | 39.02M | 26.84M | 20.54M | 11.52M | 6.71M | 55.73M | 58.59M | 37.66M | 19.19M | -6.33M | 36.47M | 36.01M | 29.22M | 32.27M | 24.96M | 16.54M | 11.88M | 10.37M | 8.62M | 6.98M | 4.1M | 4.8M | 3.5M |
| Net Interest Income | -18.22M | -16.56M | -16.55M | -12.27M | -3.95M | -3.62M | -5.18M | -7.21M | -4.02M | -1.94M | -1.62M | -2.56M | -2.47M | -1.19M | -1.75M | -3.46M | -3.02M | -3.21M | -3.97M | 214K | 30K | 392K | 85K | 626K | 371.4K | 18.9K | 38.6K | 0 | 0 | 0 | 0 |
| Interest Income | 2K | 106K | 230K | 368K | 167K | 65K | 89K | 182K | 174K | 41K | 7K | 0 | 19K | 1K | 1K | 3K | 0 | 44K | 75K | 214K | 30K | 392K | 85K | 626K | 371.4K | 18.9K | 38.6K | 0 | 0 | 0 | 0 |
| Interest Expense | 18.22M | 16.67M | 16.78M | 12.64M | 4.12M | 3.69M | 5.27M | 7.39M | 4.2M | 1.98M | 1.63M | 2.14M | 2.49M | 1.19M | 1.75M | 3.46M | 3.02M | 3.25M | 4.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -51.59M | -60.97M | -18.9M | -13M | -4.69M | -4.19M | -4.59M | -7.42M | -5.42M | -1.94M | -1.62M | -2.56M | -3.07M | -1.9M | -2.47M | -4M | -3.02M | -3.21M | -3.97M | -5.49M | -2.69M | -1.33M | -1.23M | -360K | -602K | -1.34M | -1.43M | -1.76M | -900K | -1.5M | -900K |
| Pretax Income | -43.15M | -47.2M | -120.46M | 10.3M | 35.97M | 26.75M | 18.32M | 18.8M | 33.6M | 24.85M | 18.92M | 8.96M | 3.64M | 53.83M | 56.85M | 35.22M | 16.17M | -9.54M | 32.17M | 30.53M | 26.55M | 30.94M | 23.73M | 16.18M | 11.28M | 9.02M | 7.19M | 5.22M | 3.2M | 3.3M | 2.6M |
| Pretax Margin % | -8.25% | -9.16% | -22.01% | 1.78% | 5.9% | 4.8% | 3.99% | 4.02% | 7.4% | 7% | 6.06% | 3.1% | 1.22% | 14.13% | 15.53% | 11.57% | 7.04% | -4.56% | 13.54% | 14.09% | 13.7% | 16.3% | 15.73% | 12.96% | 11.2% | 10.37% | 9.21% | 7.55% | 4.78% | 4.87% | 5.35% |
| Income Tax | 2.42M | 2.68M | 5.88M | 2.78M | 8.56M | 8.17M | 3.08M | 5.2M | 9.14M | 4.44M | 5.54M | 2.01M | -451K | 18.92M | 20.03M | 13.15M | 5.19M | -3.75M | 12.15M | 11.8M | 11.07M | 11.94M | 9.26M | 5.92M | 4.23M | 3.38M | 2.87M | 1.99M | 1.1M | 1.3M | 1M |
| Effective Tax Rate % | -5.6% | -5.68% | -4.88% | 26.98% | 23.8% | 30.52% | 16.81% | 27.67% | 27.22% | 17.88% | 29.29% | 22.42% | -12.38% | 35.14% | 35.22% | 37.35% | 32.09% | 39.31% | 37.78% | 38.65% | 41.71% | 38.58% | 39% | 36.58% | 37.5% | 37.5% | 40% | 38.05% | 34.38% | 39.39% | 38.46% |
| Net Income | -45.56M | -49.88M | -126.34M | 7.52M | 27.4M | 18.59M | 15.24M | 13.6M | 24.2M | 20.27M | 12.79M | 6.59M | 4.84M | 34.45M | 36.87M | 22.07M | 10.98M | -5.79M | 20.02M | 18.73M | 15.45M | 19M | 14.48M | 10.26M | 7.05M | 5.64M | 4.31M | 3.24M | 2.1M | 2M | 1.6M |
| Net Margin % | -8.71% | -9.68% | -23.08% | 1.3% | 4.5% | 3.33% | 3.32% | 2.9% | 5.33% | 5.71% | 4.1% | 2.28% | 1.62% | 9.04% | 10.07% | 7.25% | 4.78% | -2.77% | 8.43% | 8.64% | 7.97% | 10.01% | 9.6% | 8.22% | 7% | 6.48% | 5.53% | 4.67% | 3.13% | 2.95% | 3.29% |
| Net Income Growth % | 66.58% | 60.52% | -1780.28% | -72.56% | 47.44% | 21.95% | 12.07% | -43.79% | 19.34% | 58.54% | 94.02% | 36.15% | -85.95% | -6.56% | 67.06% | 100.91% | 289.74% | -128.92% | 6.89% | 21.23% | -18.7% | 31.26% | 41.06% | 45.6% | 24.99% | 30.81% | 33.25% | 54.07% | 5% | 25% | -48.39% |
| Net Income (Continuing) | -45.56M | -49.88M | -126.34M | 7.52M | 27.4M | 18.59M | 15.24M | 13.6M | 24.06M | 20.36M | 13.02M | 6.32M | 4.09M | 33.93M | 36.83M | 22.07M | 10.98M | -5.79M | 20.02M | 18.73M | 15.45M | 19M | 14.48M | 10.26M | 7.05M | 5.64M | 4.31M | 3.24M | 2.1M | 2M | 1.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 254K | 167K | -69K | -634K | -158K | 359K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 101.7K | 0 | 0 | 0 |
| EPS (Diluted) | -1.59 | -1.75 | -4.50 | 0.26 | 0.92 | 0.61 | 0.51 | 0.46 | 0.81 | 0.68 | 0.44 | 0.23 | 0.17 | 1.19 | 1.28 | 0.79 | 0.40 | -0.21 | 0.73 | 0.68 | 0.57 | 0.74 | 0.57 | 0.41 | 0.29 | 0.24 | 0.18 | 0.14 | 0.09 | 0.09 | 0.07 |
| EPS Growth % | 67.56% | 61.11% | -1830.77% | -71.74% | 50.82% | 19.61% | 10.87% | -43.21% | 19.12% | 54.55% | 91.3% | 35.29% | -85.71% | -7.03% | 62.03% | 97.5% | 290.48% | -128.77% | 7.35% | 19.3% | -22.97% | 29.82% | 39.02% | 41.38% | 20.83% | 33.33% | 28.57% | 59.45% | -5.18% | 37.8% | -48.31% |
| EPS (Basic) | - | -1.75 | -4.50 | 0.27 | 0.94 | 0.62 | 0.52 | 0.47 | 0.83 | 0.70 | 0.44 | 0.23 | 0.17 | 1.22 | 1.32 | 0.80 | 0.40 | -0.21 | 0.75 | 0.71 | 0.60 | 0.78 | 0.61 | 0.44 | 0.30 | 0.25 | 0.18 | 0.14 | 0.09 | 0.09 | 0.07 |
| Diluted Shares Outstanding | 28.65M | 28.43M | 28.06M | 28.53M | 29.87M | 30.41M | 29.99M | 29.66M | 30.05M | 29.7M | 29.39M | 29.24M | 28.91M | 28.9M | 28.76M | 27.88M | 27.65M | 27.12M | 27.47M | 27.44M | 27.19M | 25.76M | 25.56M | 24.84M | 24.24M | 23.66M | 24.06M | 23.96M | 24.22M | 20.04M | 23.94M |
| Basic Shares Outstanding | 28.65M | 28.43M | 28.06M | 28.13M | 29.23M | 29.81M | 29.45M | 29.03M | 29.33M | 29.1M | 28.86M | 28.67M | 28.44M | 28.3M | 27.91M | 27.56M | 27.39M | 27.12M | 26.64M | 26.31M | 25.93M | 24.34M | 23.95M | 23.5M | 23.12M | 22.95M | 23.67M | 23.96M | 24.22M | 20.04M | 23.94M |
| Dividend Payout Ratio | - | - | - | 45.01% | 10.17% | 12.82% | 7.66% | 17.08% | 9.09% | 7.89% | 4.52% | 17.31% | 117.17% | 13.95% | 16.68% | 9.99% | 7.46% | - | 10.62% | 9.81% | 14.01% | 8.16% | 8.12% | 7.86% | 8.5% | 8.15% | 10.54% | 4.62% | 9.52% | 10% | 6.25% |
Regulatory EPA molecule bans
As indicated by the most recent quarterly data, American Vanguard's revenue growth remains highly inconsistent, with a 6.7% increase in 2026Q1 following a 9.0% contraction in 2025Q4, reflecting the inherent challenges of managing a seasonal, agriculture-dependent portfolio in a volatile commodity price environment.
The revenue trajectory suggests that the company is struggling to maintain consistent demand, likely exacerbated by channel inventory de-stocking cycles. Investors should monitor whether the recent growth in 2026Q1 represents a sustainable recovery or merely a temporary rebound from the significant contraction observed in late 2025.
Based on reported financial statements, gross margins have fluctuated significantly, bottoming out at 13.8% in 2024Q4 before recovering to 31.1% in 2026Q1, highlighting the sensitivity of the company's off-patent chemical portfolio to raw material cost spikes and inventory valuation adjustments.
The inability to consistently maintain gross margins above 30% suggests limited pricing power, as the company lacks the protection of new, proprietary molecules. This margin profile implies that profitability is highly susceptible to external cost pressures and the timing of regulatory-driven inventory write-downs.
According to the income statement history, operating income has frequently turned negative, with a notable operating margin of -42.3% in 2024Q4, demonstrating that the company's fixed cost base is currently too high to support its fluctuating revenue levels during periods of operational stress.
The lack of consistent operating leverage indicates that SG&A and R&D expenses are not scaling efficiently with revenue. This suggests that management may need to rationalize the cost structure further if they are to achieve sustainable profitability in the absence of significant top-line growth.
As reported in recent filings, American Vanguard has struggled to generate positive net income, with a net margin of -9.68% recently, a trend that appears driven by both operational inefficiencies and the impact of non-operating items on the bottom line.
The recurring net losses warrant further investigation into whether these are purely operational or if they reflect ongoing impairments related to the legacy portfolio. Investors should be cautious of the quality of earnings until the company can demonstrate a sustained return to positive net income.
Based on the provided data and industry context, the most significant risk to the income statement is the potential for accelerated EPA restrictions on organophosphates, which could render a substantial portion of the company's revenue-generating assets obsolete in the near term.
Short-sellers would likely focus on the vulnerability of the company's legacy chemical portfolio to regulatory shifts, which could force expensive portfolio turnover. This risk profile suggests that the current valuation may not fully account for the potential loss of key revenue streams due to environmental compliance.
Quick answers to the most common questions about buying AVD stock.
For fiscal year 2025, American Vanguard Corporation (AVD) reported total revenue of $515.1M. This represents a 959.9% increase compared to $48.6M in 1996.
American Vanguard Corporation (AVD) reported a net loss of $49.9M for the fiscal year ending 2025.
American Vanguard Corporation (AVD) reported an operating income of $13.8M, resulting in an operating profit margin of 2.7%. This margin reflects the operational efficiency of the business before interest and taxes.
American Vanguard Corporation (AVD) generated $147.6M in gross profit for the year, representing a gross profit margin of 28.6%. This demonstrates the company's core pricing power and production efficiency.